James O. Wilson

Array ( [id] => 4080076 [patent_doc_number] => 06024941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'External skin treatment composition' [patent_app_type] => 1 [patent_app_number] => 8/429905 [patent_app_country] => US [patent_app_date] => 1995-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17324 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/024/06024941.pdf [firstpage_image] =>[orig_patent_app_number] => 429905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660557 [patent_doc_number] => 05591843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-07 [patent_title] => '5-modified pyrimidines from palladium catalyzed carbon-carbon coupling' [patent_app_type] => 1 [patent_app_number] => 8/423395 [patent_app_country] => US [patent_app_date] => 1995-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7949 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/591/05591843.pdf [firstpage_image] =>[orig_patent_app_number] => 423395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730453 [patent_doc_number] => 05703218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Oligonucleotides containing hydroxyl-protecting groups orthogonally removable by reduction' [patent_app_type] => 1 [patent_app_number] => 8/421798 [patent_app_country] => US [patent_app_date] => 1995-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4602 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/703/05703218.pdf [firstpage_image] =>[orig_patent_app_number] => 421798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157611 [patent_doc_number] => 06156737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Use of dideoxy nucleoside analogues in the treatment of viral infections' [patent_app_type] => 1 [patent_app_number] => 8/416746 [patent_app_country] => US [patent_app_date] => 1995-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4095 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156737.pdf [firstpage_image] =>[orig_patent_app_number] => 416746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732933 [patent_doc_number] => 05635610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Production of saccharide carboxylic acids' [patent_app_type] => 1 [patent_app_number] => 8/419394 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 13690 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635610.pdf [firstpage_image] =>[orig_patent_app_number] => 419394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732954 [patent_doc_number] => 05635611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Production of saccharide carboxylic acids' [patent_app_type] => 1 [patent_app_number] => 8/419397 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 13696 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635611.pdf [firstpage_image] =>[orig_patent_app_number] => 419397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3610765 [patent_doc_number] => 05589587 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Process for the preparation of ribonucleotide reductase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/419315 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9801 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589587.pdf [firstpage_image] =>[orig_patent_app_number] => 419315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516516 [patent_doc_number] => 05512671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-30 [patent_title] => 'Ether lipid-nucleoside covalent conjugates' [patent_app_type] => 1 [patent_app_number] => 8/418853 [patent_app_country] => US [patent_app_date] => 1995-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8794 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/512/05512671.pdf [firstpage_image] =>[orig_patent_app_number] => 418853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818985 [patent_doc_number] => 05770725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Phosphotriester type biologically active compounds' [patent_app_type] => 1 [patent_app_number] => 8/416515 [patent_app_country] => US [patent_app_date] => 1995-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8258 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770725.pdf [firstpage_image] =>[orig_patent_app_number] => 416515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3539416 [patent_doc_number] => 05494935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-02-27 [patent_title] => 'Methods for oral decorporation of metals' [patent_app_type] => 1 [patent_app_number] => 8/415361 [patent_app_country] => US [patent_app_date] => 1995-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 14219 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/494/05494935.pdf [firstpage_image] =>[orig_patent_app_number] => 415361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657643 [patent_doc_number] => 05658893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Method for inhibition of rotavirus infection with carrageenan' [patent_app_type] => 1 [patent_app_number] => 8/412808 [patent_app_country] => US [patent_app_date] => 1995-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3617 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658893.pdf [firstpage_image] =>[orig_patent_app_number] => 412808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1361886 [patent_doc_number] => 06573374 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Nucleotides labelled with an infrared dye and their use in nucleic acid detection' [patent_app_type] => B1 [patent_app_number] => 08/411761 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2916 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573374.pdf [firstpage_image] =>[orig_patent_app_number] => 08411761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3703215 [patent_doc_number] => 05646265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Process for the preparation of 2\'-O-alkyl purine phosphoramidites' [patent_app_type] => 1 [patent_app_number] => 8/410002 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18801 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646265.pdf [firstpage_image] =>[orig_patent_app_number] => 410002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3684421 [patent_doc_number] => 05633361 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Method for palladium catalyzed carbon-carbon coupling and products' [patent_app_type] => 1 [patent_app_number] => 8/407893 [patent_app_country] => US [patent_app_date] => 1995-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7904 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633361.pdf [firstpage_image] =>[orig_patent_app_number] => 407893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770039 [patent_doc_number] => 05733893 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Method of identifying molecules that regulate FGF activity' [patent_app_type] => 1 [patent_app_number] => 8/404655 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 6185 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733893.pdf [firstpage_image] =>[orig_patent_app_number] => 404655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1220864 [patent_doc_number] => 06703396 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-09 [patent_title] => 'Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers' [patent_app_type] => B1 [patent_app_number] => 08/402730 [patent_app_country] => US [patent_app_date] => 1995-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8427 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703396.pdf [firstpage_image] =>[orig_patent_app_number] => 08402730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3518116 [patent_doc_number] => 05576429 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => '5-substituted pyrimidine nucleosides and nucleotides' [patent_app_type] => 1 [patent_app_number] => 8/395877 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11232 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576429.pdf [firstpage_image] =>[orig_patent_app_number] => 395877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591969 [patent_doc_number] => 05585512 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Esters of p-hydroxyaniline mustard' [patent_app_type] => 1 [patent_app_number] => 8/394814 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4144 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585512.pdf [firstpage_image] =>[orig_patent_app_number] => 394814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3600575 [patent_doc_number] => 05559222 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Preparation of 1-(2\'-deoxy-2\',2\'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-.beta.-D-ribo-pentopyranose' [patent_app_type] => 1 [patent_app_number] => 8/383165 [patent_app_country] => US [patent_app_date] => 1995-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4638 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559222.pdf [firstpage_image] =>[orig_patent_app_number] => 383165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775801 [patent_doc_number] => 05808043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Composition for stabilization of labelled nucleoside triphosphates and methods for using same' [patent_app_type] => 1 [patent_app_number] => 8/374456 [patent_app_country] => US [patent_app_date] => 1995-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4638 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808043.pdf [firstpage_image] =>[orig_patent_app_number] => 374456 [rel_patent_id] =>[rel_patent_doc_number] =>)